Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEC order granting confidential treatment

What is it that Patriot would have amended on Feb 4, 2013, right before TPL filed BK on March 20. Can we petition the SEC to make these docs public in light of all the evidence coming out of the BK to support that DL has been controlling every move by PTSC? Maybe one of our legal experts would be willing to contact the special counsel for the SEC listed below.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
February 14, 2013
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Patriot Scientific Corporation
File No. 000-22182- CF#28616
_____________________
Patriot Scientific Corporation submitted an application under Rule 24b-2
requesting confidential treatment for information it excluded from the Exhibits to a Form
8-K filed on July 17, 2012, as amended on February 4, 2013.
Based on representations by Patriot Scientific Corporation that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.7 through July 17, 2017
Exhibit 10.8 through July 17, 2017
Exhibit 10.9 through July 17, 2017
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Maryse Mills-Apenteng
Special Counsel

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=PTSC&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Share
New Message
Please login to post a reply